Celldex Therapeutics, Inc. (CLDX) vs Clover Health Investments, Corp. (CLOV)

A side-by-side comparison of Celldex Therapeutics, Inc. and Clover Health Investments, Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CLDX vs CLOV

growth of $100 · dividends reinvested · last 6y
CLDX +317.8% (+26.9%/yr)CLOV -53.6% (-12.0%/yr)CLDX compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202120222023202420252026$418$46
CLDX CLOV

CLDX vs CLOV: by the numbers

  • •CLOV is the larger company ($2.43B vs $2.17B market cap).
  • •Both run net losses; CLOV's is the smaller (-0.74% vs -268385.71% net margin).
  • •CLOV grew revenue faster over the past five years (21.18% vs -58.05% CAGR).

Metrics side by side

Valuation

MetricCLDXCLOV
Forward P/EN/A83.51
P/S ratio19361.500.98
P/B ratio3.036.45
FCF yieldN/A3.06%

Profitability

MetricCLDXCLOV
Gross margin100.00%18.57%
Operating margin-19160.00%-0.74%
Net margin-268385.71%-0.74%
ROE-42.07%-4.88%
ROIC-45.19%-4.62%

Growth (annualized)

MetricCLDXCLOV
Revenue CAGR (5Y)-58.05%21.18%
Total return CAGR (5Y)-10.28%-8.36%

Frequently asked

Which has grown faster, CLDX or CLOV?
Over the past five years, CLOV grew revenue faster — CLDX at a -58.05% CAGR versus CLOV at 21.18%.
How have CLDX and CLOV total returns compared?
Over the past 5 years, CLDX delivered -10.28% and CLOV delivered -8.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.